Affibody has reported positive Phase 1 data from its licensee [...]

ViiV Healthcare will present new data from its long-acting and [...]

Oncoinvent will present final 24-month follow-up data from its Phase [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

CERo Therapeutics has reported early clinical findings from its ongoing [...]

Orano Med has advanced its long-running collaboration with Roche as [...]

nChroma Bio has presented new preclinical data supporting its lead [...]

Heidelberg Pharma has reported further clinical activity from its Phase [...]

Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

Alys Pharmaceuticals has submitted a clinical trial application (CTA) in [...]